Over­worked and ready for ex­pan­sion: FDA's cell and gene ther­a­py of­fice preps to add about 100 new po­si­tions

Housed with­in the FDA’s Cen­ter for Bi­o­log­ics Eval­u­a­tion and Re­search, the once-tiny Of­fice of Tis­sues and Ad­vanced Ther­a­pies, which reg­u­lates all cell and gene ther­a­py …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER